Global Liquid Embolic Device Market Growth 2025-2031

The global Liquid Embolic Device market size is predicted to grow from US$ 206 million in 2025 to US$ 263 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

Liquid Embolic Device is a premixed, radiopaque, injectable embolic fluid designed for preoperative embolization of cerebral arteriovenous malformations (bAVMs).

A liquid embolization device is a medical device used for interventional endovascular therapy. It is used to embolize (seal off) abnormal blood vessels or vascular malformations in blood vessels, and is often used to treat conditions such as aneurysms and arteriovenous malformations. The working principle of the liquid embolization device is to inject a specific type of liquid or colloid material into the abnormal blood vessel to form an embolism, prevent the abnormal blood flow, and finally cause the abnormal blood vessel to be occluded. Liquid embolic devices are usually guided by a long, thin catheter (guide wire) to the location of the target blood vessel, which then releases the liquid embolic material.

LP Information, Inc. (LPI) ' newest research report, the “Liquid Embolic Device Industry Forecast” looks at past sales and reviews total world Liquid Embolic Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Liquid Embolic Device sales for 2025 through 2031. With Liquid Embolic Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Embolic Device industry.

This Insight Report provides a comprehensive analysis of the global Liquid Embolic Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liquid Embolic Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid Embolic Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Embolic Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Embolic Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Embolic Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Liquid Embolic Vials
Liquid Embolic Prefilled Injectables

Segmentation by Application:
Brain Arteriovenous Malformation
Brain Aneurysm
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Meril Life Sciences
Medtronic
Johnson and Johnson
MicroVention
Terumo Corporation
Balt
Saikesaisi Biological Technology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liquid Embolic Device market?

What factors are driving Liquid Embolic Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liquid Embolic Device market opportunities vary by end market size?

How does Liquid Embolic Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.